The Shift To Home Dialysis Will Erode Core Revenues
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
18 Jun 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
€40.00
9.0% overvalued intrinsic discount09 Aug
€43.60
1Y
26.3%7D
2.3%